Canada: NAFTA 2.0: The Wide-Ranging Impact Of USMCA

The September 30 agreement that renegotiates NAFTA—United States-Mexico-Canada Agreement (USMCA)—updates the more than two decade old trade deal.

USMCA makes substantial changes to a number of NAFTA chapters. Below we discuss some of the key changes to the provisions regarding investment protections and dispute resolution, automotive manufacturing, privacy, digital trade, and intellectual property. We also comment on the continued steel and aluminum tariffs.

Investment Protections

Although the protections for investments and investors previously set out in NAFTA survive largely intact in USMCA, there are significant changes as to how breaches of those protections are resolved.

So, what are those protections? Broadly speaking, they are:

  • national treatment and most-favored-nation treatment, which require USMCA parties to treat investors from other USMCA parties "no less favourably" than they treat their own investors or investors from third states,
  • minimum standard of treatment, which requires USMCA parties to accord "fair and equitable treatment and full protection and security" to the investments of investors from other parties, and
  • expropriation and compensation, which prohibits USMCA parties from expropriating the investments of investors from other parties USMCA payment of fair compensation.

Although these protections largely remain in USMCA, the broad right that investors had under NAFTA Chapter 11 to invoke arbitration for breaches of these protections has been phased out (subject to the grace period described below). Previously, Chapter 11 permitted any investor from a NAFTA party with an investment in the territory of another party to bring a claim for loss or damages to the investment. Numerous investors have relied on that procedure to bring claims against Canada, Mexico and, to a lesser extent, the United States.

Chapter 14 of USMCA, which replaces NAFTA Chapter 11, maintains an arbitration procedure between the U.S. and Mexico, but completely excludes Canada. As a result, Canadian investors in the U.S., U.S. investors in Canada, Canadian investors in Mexico, and Mexican investors in Canada, will not have access to arbitration for breaches of USMCA's protections. The only recourse open to these investors under USMCA is a claim against the host state on their behalf by their home state under Chapter 31.

While broader, the right of U.S. and Mexican investors to claim against those governments has likewise been narrowed in USMCA. Investors' claims will be limited to disputes regarding certain "covered government contracts" in specified sectors, including oil and natural gas, transportation, and telecommunications.

USMCA includes transitional provisions for legacy investment claims and pending claims. Legacy claims (i.e., claims in respect of investments made before USMCA enters into force) may be commenced up to three years after USMCA enters into force. Investors in Canada, and Canadian investors in the U.S. concerned about treaty protections for their investments may want to consider how they can benefit from similar protections under Canada's other investment protection treaties.

Privacy

USMCA does not require Canada to strengthen its existing privacy regime, as it was under CETA. USMCA provides a flexible approach to the type of legal framework that would satisfy its privacy requirements. A party therefore complies if it adopts or maintains measures such as a comprehensive privacy law, sector-specific laws, or laws that provide for the enforcement of voluntary undertakings by enterprises relating to privacy.

Interestingly, USMCA encourages cooperation between the parties' privacy regulators on investigations and developing mechanisms for users to submit complaints. This approach is in line with the global trend steering away from competing over jurisdiction.

Digital Trade

Chapter 19 contains most of USMCA's digital trade provisions. It specifically prohibits parties from imposing duties on digital products transmitted electronically or according less favourable treatment to digital products produced by another party. USMCA brings safe harbour provisions into Canada, which don't hold companies—such as internet providers—liable for content posted by third parties or their good faith removal of objectionable content. Chapter 19 also enacts anti-spam provisions similar to those that already exist under Canadian law.

USMCA significantly relaxes geographical restrictions on data storage which will greatly help e-commerce businesses.

Chapter 19 includes other provisions that further ease the conduct of business. For instance, parties are required to treat e-signatures as having equivalent legal validity to a physical signature, except where prescribed by law. Canada's permissive provincial and federal e-signature regimes are therefore in line with these USMCA requirements.

USMCA significantly relaxes geographical restrictions on data storage. This will greatly help e-commerce businesses, which will no longer be required to have a physical presence in a particular jurisdiction as a condition of doing business there. However, there are a few limitations: for example, under Chapter 17, parties can adopt measures requiring financial services organizations to get regulatory approval before outsourcing information management to vendors.

Intellectual Property

When it takes effect, USMCA will make a number of important changes to intellectual property protections in Canada. This article focuses on extended terms of data protection for new biologic drugs and a new patent term adjustment mechanism.

Biologic drugs are products produced using biotechnology processes, such as vaccines, antibodies, toxins or genetic therapies, and are unlike the chemical (small molecule) compounds that are the active ingredient in many pharmaceutical products. Biologics are complex molecules and the process of making a biologic drug is typically proprietary; however, it can be difficult to enforce patents directed to production methods, so, arguably, other tools are needed to encourage innovation into biologic development.

Presently, "innovative" drugs that contain a medicinal ingredient not previously approved in a drug by Health Canada are entitled to an eight-year term of data protection (with a six-month extension for pediatric indications). Data protection is independent of patent protection—it is an exclusivity period during which Health Canada will not approve a generic or biosimilar (a copy) of the innovative drug. The current eight-year period of exclusivity applies to both new biologic drug products and new small molecule drugs. When it enters into force, USMCA will add an additional two years of exclusivity for biologic drug products, meeting the current definition of innovative drug. This is still less than the 12-year period for biologics granted by the U.S. Food and Drug Administration. New small molecule drugs will continue to be entitled to only eight years of data protection.

The timing of changes to IP rules depends on the uncertain timing of the ratification and implementation of USMCA.

Under USMCA, Canada will also provide a mechanism to adjust the term of a patent to compensate an applicant for unnecessary or unreasonable delay in processing a patent application (later than five years from the date of filing a patent application, or three years from the date a request for examination of a patent application). Patent term adjustment has been available in the U.S. for some time. Several exclusions under USMCA make it uncertain how "unreasonable delay" will be applied in practice by the Canadian Intellectual Property Office (CIPO) (i.e., it appears that CIPO will be able to "stop the clock" in various circumstances), so it is unclear at this time how many patent applications will benefit from an adjustment. USMCA does not specify a maximum term for the patent extension.

These changes are significant and bring Canada more closely in line with U.S. IP rights. It is notable that Canada has been on the "watch list" of the Office of the United States Trade Representative as a country that does not adequately protect or enforce patent rights. The timing of changes to IP rules depends on the uncertain timing of the ratification and implementation of USMCA. It is also still unclear whether these changes will apply retroactively to any previously approved biologic drug products or previously issued patents; however based on past reform in this area, drug manufacturers and patentees should not expect that these benefits will be applied to approved drugs and/or issued patents as of the coming into force date.

Steel and Aluminum Tariffs

The 10% tariff on steel originating in Canada and 25% tariff on aluminum originating in Canada, imposed by the U.S. earlier this year on "national security" grounds under the Trade Expansion Act of 1962, remain in place under USMCA. The equivalent tariffs imposed by Canada on steel and aluminum originating in the U.S. also remain in place.

These steel and aluminum tariffs were not addressed in the main body of USMCA. Instead, they are the subject of a "side-letter" between Canada and the U.S.; the so-called U.S.-Canada 232 Side Letter, acknowledging that the U.S. may impose future measures under section 232 of the Trade Expansion Act of 1962. However, if it does, the U.S. "shall exclude from the measure":

  • 2,600,000 passenger vehicles imported from Canada on an annual basis;
  • light trucks imported from Canada; and
  • such quantity of auto parts amounting to US$32.4 billion in declared customs value in any calendar year.

Under the Side Letter, Canada's ability to submit claims related to section 232 measures to state-to-state dispute resolution under NAFTA Chapter 20 or USMCA Chapter 10 (whichever is in effect at the time) is limited. Specifically, Canada's ability to do so is limited to claims with respect to whether the U.S. excluded the number of passenger vehicles and light trucks, and the value of auto parts, as set out above. In practice, this gives the U.S. fairly wide latitude to impose steel and aluminum tariffs in the future, and limits Canada's ability to submit those tariffs to dispute resolution.

Existing U.S. tariffs on Canadian aluminum and steel remain subject to separate negotiation outside USMCA.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions